Decay-accelerating factor promotes endometrial cells proliferation and motility under ovarian hormone stimulation

• Published in: Reproductive biology Vol. 18; no. 3; pp. 225 - 235
• Main Authors: Wang, Lu, Zhang, Wei, Guan, Hai-Yun
• Format: Journal Article
• Language: English
• Published: Poland 01.09.2018
• Subjects: Adult; CD55 Antigens - metabolism; Cell Movement - drug effects; Cell Movement - physiology; Cell Proliferation - drug effects; Cell Proliferation - physiology; Dose-Response Relationship, Drug; Endometrium - cytology; Endometrium - drug effects; Endometrium - metabolism; Estradiol - pharmacology; Female; Humans; Mifepristone - pharmacology; Progesterone - pharmacology; Stromal Cells - cytology; Stromal Cells - drug effects; Stromal Cells - metabolism; Tamoxifen - pharmacology; Hormone; DAF; Motility; Proliferation; Endometrial receptivity
• ISSN: 1642-431X; 2300-732X
• DOI: 10.1016/j.repbio.2018.07.004

The intent of the study was to explore the elevating expression of decay-accelerating factor(DAF) exerts influence on biological behaviors of endometrial stromal cells except in classical immunology on the basis of bioinformatic statistics and clinical miscarriages findings suggesting its potential role in the establishment of endometrial receptivity. We confirmed that DAF locates on the cellular surface of endometrial epithelium and stroma. By using plasmid transfection to down-regulate DAF expression in primary endometrial stromal cells(ESCs), we discovered that DAF expression in ESCs increases in response to estradiol and progesterone stimulation in dose- and time-dependent manners; moreover, tamoxifen and RU486 stimulations to block estrogen receptors(ERs) and progesterone receptors(PRs) respectively result in reduced DAF mRNA and protein, and it is more obvious to block PRs. Meanwhile, knocked-down DAF in ESCs weakens the proliferation, migration and invasion of endometrial cells. Cell cycle analysis showed knocked-down DAF accumulates cells in S phase and diminishes cells in G0/G1 phase, which substantiates DAF mediates endometrial cells proliferation. In conclusion, DAF is a potential molecule involving in endometrial cellular proliferation and motility to verify up-expressed DAF during the WOI may facilitate endometrial physiobiological behavior changes, which shed light on DAF function and potential role in the endometrial receptivity establishment.